临床儿科杂志 ›› 2022, Vol. 40 ›› Issue (1): 27-.doi: 10.12372/jcp.2022.21e0842

• 血液/ 肿瘤疾病专栏 • 上一篇    下一篇

化疗对急性淋巴细胞白血病患儿性腺功能的影响

曹科 1, 罗小娟 1, 王缨 2, 刘霞 3, 叶炳均 1, 陈诗杨 1, 赖建威 1, 龙庆玲 2, 陈运生 1   

  1. 深圳市儿童医院 1.检验科,2 .血液肿瘤科,3 .内分泌科(广东深圳 518038)
  • 出版日期:2022-01-15 发布日期:2022-01-11
  • 通讯作者: 罗小娟 电子信箱:luoxiaojuan 1983 @ 126 .com
  • 基金资助:
    深圳市卫生计生系统科研项目(No.SZFZ2018054);深圳市科技研发资金(No.JCYJ20180228175408411)

The in luence of chemotherapy on gonadal function in acute lymphoblastic leukemia children

n CAO Ke 1 , LUO Xiaojuan1 , WANG Ying2 , LIU Xia3 , YE Bingjun1 , CHEN Shiyang1 , LAI Jianwei 1 , LONG Qingling2 , CHEN Yunsheng1   

  1. 1 .Department of Laboratory, 2 .Department of Hematological Oncology, 3 .Department of Endocrinology, Shenzhen Children's Hospital, Shenzhen 518038, Guangdong, China
  • Online:2022-01-15 Published:2022-01-11

摘要: 目的 研究不同强度的化疗对急性淋巴细胞白血病(ALL)儿童性腺功能激素指标的影响。方法 依据 华南地区儿童ALL治疗协助组2016化疗方案(SCCLG-ALL- 2016),对112例青春期前初发ALL儿童进行队列研究, 采用化学发光法检测化疗前、化疗后3、6、12、18月的血清抗缪勒管激素(AMH)和抑制素B(INHB)激素水平,按照 性别及危险度分型分组进行比较。结果 共纳入112例ALL患儿,男58例、女54例,中位年龄4.1(2.5~6.1)岁;高 危型24例、中危型58例、低危型30例。正常对照组57例,男28例、女29例,中位年龄4.0(2.5~6.3)岁。采用重复测 量方差分析发现,男童低危型、中危型、高危型之间血清INHB水平差异有统计学意义(F=3.60,P=0 . 036),化疗前后 不同时间之间血清INHB水平差异有统计学意义(F=81 . 67,P<0.001)。女童低危型、中危型、高危型之间血清AMH水平差异无统计学意义(F= 0 . 62, P=0 . 551),化疗前后不同时间之间血清AMH水平差异有统计学意义(F=21 . 32,P

关键词: 抗缪勒管激素; 抑制素B; 化疗; 性腺功能; 急性淋巴细胞白血病

Abstract: Objective To investigate the influence of different intensity of chemotherapy on hormonal markers of gonadal function in children with acute lymphoblastic leukemia (ALL). Methods Based on the chemotherapy regimens of South China children's leukemia Group (SCCLG-ALL- 2016 ), a total of 112 newly diagnosed ALL preadolescent were included. Serum anti-Müllerian hormone (AMH) and inhibin B (INHB) levels were detected by chemiluminescence assay before and 3 , 6 , 12 and 18 months after chemotherapy, and were compared according to gender and risk type. Results A total of 112 patients ( 58 boys and 54 girls) with ALL were enrolled, with a median age of 4 . 1 ( 2 . 5 - 6 . 1 ) years. There were 24 high-risk children, 58 medium-risk children, and 30 low-risk children. In the normal control group, there were 57 patients ( 28 boys and 29 girls), with a median age of 4 . 0 ( 2 . 5 - 6 . 3 ) years. Repeated measures analysis of variance showed that there were statistically significant differences in serum INHB levels among low-risk, medium-risk and high-risk boys (F= 3 . 60 , P= 0 . 036 ) at different times before and after chemotherapy (F= 81 . 67 , P< 0 . 001 ). Time of chemotherapy and risk type had an interaction effect on serum INHB level (F=5.12, P< 0 . 001 ). There was no statistically significant difference in serum AMH level between low-risk, medium-risk and high-risk girls (F= 0 . 62 , P= 0 . 551 ), and there was statistically significant difference in serum AMH level between different time before and after chemotherapy (F=21 . 32 , P< 0 . 001 ). Time of chemotherapy and risk type had an interaction effect on serum AMH level (F=2.33, P= 0 . 029 ). Conclusions Although the children with ALL were still prepubertal, SCCLG-ALL- 2016 chemotherapy could change the hormonal markers of gonadal function. Moreover, the influence degree of high-risk chemotherapy was higher than that of low and medium risk chemotherapy, suggesting that gonadal function of children with ALL was impaired to varying degrees during chemotherapy.

Key words: anti-Müllerian hormone; inhibin B; chemotherapy; gonadal function; acute lymphoblastic leukemi